gold has been researched along with crizotinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Gao, W; Sun, Y; Tang, B; Wei, X; Xu, K; Zhang, H | 1 |
| Ben-Aharon, I; Betzer, O; Bragilovski, D; Hadar, T; Haviv, I; Hazkani, I; Levi, M; Lubimov, L; Mizrachi, A; Motiei, M; Popovtzer, A; Popovtzer, R; Sadan, T | 1 |
2 other study(ies) available for gold and crizotinib
| Article | Year |
|---|---|
AuNP flares-capped mesoporous silica nanoplatform for MTH1 detection and inhibition.
Topics: Animals; Base Sequence; Cell Line, Tumor; Crizotinib; DNA Repair Enzymes; DNA, Single-Stranded; Enzyme Inhibitors; Gold; Humans; Male; Mice; Mice, Nude; Nanoparticles; Neoplasms; Phosphoric Monoester Hydrolases; Pyrazoles; Pyridines; RNA, Messenger; Silicon Dioxide | 2015 |
Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma.
Topics: Anaplastic Lymphoma Kinase; Carcinoma, Adenoid Cystic; Crizotinib; Gold; Humans; Metal Nanoparticles; Mutation; Pyrazoles; Pyridines; Receptor Protein-Tyrosine Kinases | 2017 |